Abbott Laboratories recently announced that it has received approval from the FDA to market a device called the Humira Pen. The Pen will be available beginning in August. The drug manufacturer developed the pen as an alternative way for patients to administer their medications. According to the Abbott Laboratories website, the Humira Pen is designed to be easy to grasp and operate. It is designed to be convenient for patients who have stiffness or limited function in the hands due to swelling.

Cu...